| P2093 | author name string | Yan Wang | |
| | Zhen Yang | |
| | Jing Li | |
| | Jun Tao | |
| | Chen Su | |
| | Fang Wu | |
| | Fei Cheng | |
| | Bing-Bo Yu | |
| | Wen-Hao Xia | |
| | Yan-Xia Qiu | |
| P2860 | cites work | Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis | Q28477076 |
| | Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress | Q29615436 |
| | Reduced arterial elasticity is associated with endothelial dysfunction in persons of advancing age: comparative study of noninvasive pulse wave analysis and laser Doppler blood flow measurement | Q33205400 |
| | Nox4 overexpression activates reactive oxygen species and p38 MAPK in human endothelial cells | Q33417366 |
| | Endothelial dysfunction as a target for prevention of cardiovascular disease | Q33610670 |
| | Role of the vascular NADH/NADPH oxidase system in atherosclerosis | Q33949682 |
| | Cardiovascular and metabolic effects of Berberine | Q34390654 |
| | Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins | Q34552498 |
| | NADPH Oxidase in Endothelial Cells: Impact on Atherosclerosis | Q35115451 |
| | Endothelial function and oxidative stress | Q35888596 |
| | Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension | Q36015782 |
| | Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. | Q36891589 |
| | NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology | Q37807273 |
| | Cellular Mechanisms Underlying the Formation of Circulating Microparticles | Q37821168 |
| | The many faces of endothelial microparticles. | Q37821169 |
| | Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. | Q39878461 |
| | Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease | Q40379249 |
| | In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. | Q40851071 |
| | A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis | Q42524986 |
| | Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers | Q44488018 |
| | Endothelium-derived microparticles impair endothelial function in vitro | Q44836488 |
| | NADPH oxidases 1 and 4 mediate cellular senescence induced by resveratrol in human endothelial cells. | Q46071129 |
| | Berberine acutely inhibits insulin secretion from beta-cells through 3',5'-cyclic adenosine 5'-monophosphate signaling pathway | Q46568252 |
| | Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine | Q46656835 |
| | Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure | Q46726712 |
| | Berberine-induced mobilization of circulating endothelial progenitor cells improves human small artery elasticity | Q46853938 |
| | Berberine-induced decline in circulating CD31+/CD42- microparticles is associated with improvement of endothelial function in humans | Q47922359 |
| | Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction | Q53477806 |
| | Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model | Q53616543 |
| | Endothelium-derived microparticles inhibit human cardiac valve endothelial cell function | Q53621313 |
| | NADH/NADPH Oxidase and Vascular Function | Q63365800 |
| | High levels of circulating endothelial microparticles in patients with acute coronary syndromes | Q73502484 |
| | Effects of severe hypertension on endothelial and platelet microparticles | Q78945402 |
| | Arterial elasticity identified by pulse wave analysis and its relation to endothelial function in patients with coronary artery disease | Q79327034 |
| | C-Reactive protein-induced endothelial microparticle generation in HUVECs is related to BH4-dependent NO formation | Q79918407 |
| | Increased circulating CD31+/CD42- microparticles are associated with impaired systemic artery elasticity in healthy subjects | Q80978402 |
| | Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes | Q81051483 |
| | Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress | Q81724759 |
| | Berberine-induced upregulation of circulating endothelial progenitor cells is related to nitric oxide production in healthy subjects | Q82061505 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| | berberine | Q176525 |
| P304 | page(s) | 936-942 | |
| P577 | publication date | 2012-03-31 | |
| P1433 | published in | International Journal of Cardiology | Q2357863 |
| P1476 | title | Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans | |
| P478 | volume | 167 | |